Skip to main content
SpringerLink
Log in

Hereditary hemochromatosis

A review of the genetics, mechanism, diagnosis, and treatment of iron overload

  • Original Article
  • Published:
Comprehensive Therapy

Abstract

Hereditary hemochrmatosis is a relatively common genetic disorder characterized by excess dietary iron absorption and deposition in tissues with resulting end-organ damage. Early diagnosis and initiation of therapeutic phlebotomy can provide a normal life expectancy for affected individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Trousseau A. Glycosurie: diabetic sucre. Clin Med Hotel Dieu Paris 1865;2:663–698.

    Google Scholar 

  2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399–408.

    Article  PubMed  CAS  Google Scholar 

  3. Pietrangelo A. Hereditary hemochromatosis—a new look at an old disease. N Engl J Med 2004;350:2383–2397.

    Article  PubMed  CAS  Google Scholar 

  4. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci 1998:95:1472–1477.

    Article  PubMed  CAS  Google Scholar 

  5. Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metaltransporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 1999;353:2120–2123.

    Article  PubMed  CAS  Google Scholar 

  6. Zoller H, Koch RO, Theurl I, et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001;120:1412–1419.

    Article  PubMed  CAS  Google Scholar 

  7. Stuart KA, Anderson GJ, Frazer DM, et al. Duodenal expression of iron transport molecules in untreated haemochromatosis subjects. Gut 2003;52:953–959.

    Article  PubMed  CAS  Google Scholar 

  8. Bissot P, Troadec M-B, Loreal O. Intestinal absorption of iron in HFE-1 Hemochromatosis: local or systemic process. J Hepatology 2004;40:702–709.

    Article  CAS  Google Scholar 

  9. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806–7810.

    Article  PubMed  CAS  Google Scholar 

  10. Walker AP, Partridge J, Srai SK, Dooley JS. Hepcidin: what every gastroenterologist should know. Gut 2004;53:624–627.

    Article  PubMed  CAS  Google Scholar 

  11. Roetto A, Papanikolaou G, Politou M et al.. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21,22.

    Article  CAS  Google Scholar 

  12. Kulaksiz H, Gehrke SG, Janetzko A, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency and renal anaemia. Gut 2004;53:735–743.

    Article  PubMed  CAS  Google Scholar 

  13. Knutson MD, Oukka M, Koss LM, et al.. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci 2005;102:1324–1328.

    Article  PubMed  CAS  Google Scholar 

  14. Bomford A. Genetics of haemochromatosis. Lancet 2002;360: 1673–1681.

    Article  PubMed  CAS  Google Scholar 

  15. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM et al. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4: 183–198.

    Article  PubMed  CAS  Google Scholar 

  16. Steinberg KK, Cogswell ME, Chang JC, et al.. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) hene in the United States. JAMA 2001;285:2216–2222.

    Article  PubMed  CAS  Google Scholar 

  17. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998;280:172–178.

    Article  PubMed  CAS  Google Scholar 

  18. Beutler E. Natural history of hemochromatosis, Mayo Clinic Proceedings 2004;79:305, 306.

    PubMed  Google Scholar 

  19. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ, Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275–278.

    Article  PubMed  CAS  Google Scholar 

  20. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 2003;31:262–267.

    Article  PubMed  CAS  Google Scholar 

  21. Ryan E, O'Keane C, Crowe J. Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 1998;24:428–432.

    Article  PubMed  CAS  Google Scholar 

  22. Distante S, Berg JP, Lande K, et al. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 1999;34:529–534.

    Article  PubMed  CAS  Google Scholar 

  23. Distate S, Berg JP, Lande K, et al. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 2000;47: 575–579.

    Article  Google Scholar 

  24. Beutler E, Felitti V, Koziol J, et al. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211–218.

    Article  PubMed  Google Scholar 

  25. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population. N Engl J Med 2005;352:1769–1778.

    Article  PubMed  CAS  Google Scholar 

  26. Hanson EH, Imperatore G, Burke W. HFE Gene and Hereditary Hemochromatosis: A HuGE (Human Genome Epidmiology) Review. Am J Epidemiol 2001;154:193–206.

    Article  PubMed  CAS  Google Scholar 

  27. Robson KJH, Merryweather-Clarke AT, Cadet E, et al. Recent advances in understanding haemochromatosis: a transition state. J Med Genet 2004;41:721–730.

    Article  PubMed  CAS  Google Scholar 

  28. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14,15

    Google Scholar 

  29. Roetto A, Totaro A, Piperno A, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555–2560.

    Article  PubMed  CAS  Google Scholar 

  30. Wallace DF, Pederson P, Dixon JL, et al. Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood 2002;100:692–694.

    Article  PubMed  CAS  Google Scholar 

  31. Kato J, Fujikawa K, Kanda M, et al. A Mutation in the iron responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191–197.

    Article  PubMed  CAS  Google Scholar 

  32. McDonnell SM, Preston BL, Jewell SA, et al. A Survey of 2,851 Patients with Hemochromatosis: Symptoms and Response to Treatment. Am J Med 1999;106:619–624.

    Article  PubMed  CAS  Google Scholar 

  33. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162–166

    Article  PubMed  CAS  Google Scholar 

  34. Brown AS, Gwinn M, Cogswell ME, Khoury MJ. Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Dishcarge Survey 1979–1997. Genet Med 2001;3:109–111.

    Article  PubMed  CAS  Google Scholar 

  35. Bulaj ZJ, Ajoika RS, Phillips JD, et al. Disease-related Conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343:1529–1535.

    Article  PubMed  CAS  Google Scholar 

  36. Moirand R, Adams P, Bicheler V et al. Clinical feature of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105–110.

    PubMed  CAS  Google Scholar 

  37. Tavill A. American association for the study of liver diseases guidelines: diagnosis and management of hemochromatosis. Hepatology 2001; 33:1321–1328.

    Article  PubMed  CAS  Google Scholar 

  38. Adams P, Brissot P, Powell LW. EASL (European Association for the Study of the Liver) international consensus conference on haemochromatosis.: part II, expert document and part III, Jury Document. J Hepatol 2000;33:487–504.

    Article  Google Scholar 

  39. Dubois-Laforgue D, Caillat-Zuchman S, Boitard C, Timsit J. Clinical characteristics of type 2 diabetes in patients with mutations of HFE. Diabetes Metab 2000;26:65–68.

    PubMed  CAS  Google Scholar 

  40. Yang Q, McDonnell SM, Khoury MJ, et al. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998;129:946–953

    PubMed  CAS  Google Scholar 

  41. Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004;127:S79-S86.

    Article  PubMed  CAS  Google Scholar 

  42. Nissen NN, Martin P. Hepatocellular Carcinoma: the high-risk patient, Yale University workshop on hepatocellular carcinoma, (Anderson JM and Kowdley KV, eds.). J Clin Gastroenterol 2002; 25:Supp 2:S79-S85.

    Article  Google Scholar 

  43. Fletcher LM, Bridle KR, Grawford DHG. Effect of alcohol on iron storage diseases of the liver. Best Pract Res Clin Gastroenterol 2003; 17:663–677.

    Article  PubMed  CAS  Google Scholar 

  44. Fletcher LM, Dixon JL, Purdie DM, et al. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281–289.

    Article  PubMed  Google Scholar 

  45. Britton RS, Bacon BR. Hereditary hemochromatosis and alcohol: a fibrogenic cocktail. Gastroenterology 2002;122:563–565.

    PubMed  Google Scholar 

  46. Jordan JM. Arthritis in hemochromatosis or iron storage disease. Curr Opin Rheumatol 2004;16:62–66.

    Article  PubMed  Google Scholar 

  47. Bradley R, Rosen M. Subfertility and gastrointestinal disease: unexplained is often undiagnosed. Obstet Gynecol Sury 2004;59:108–117.

    Article  Google Scholar 

  48. Edwards C, Kelly T, Ellwein G, Kushner J. Thyroid disease in hemochromatosis. Increased incidence in homozygous men. Arch Intern Med 1983;143:1890–1893.

    Article  PubMed  CAS  Google Scholar 

  49. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107–1119.

    Article  PubMed  CAS  Google Scholar 

  50. Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatos. N Engl J Med 1985;313:1256–1262.

    Article  PubMed  CAS  Google Scholar 

  51. Morrison E, Brandhagen D, Phatak P, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;138:627–633.

    PubMed  CAS  Google Scholar 

  52. Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;138:627–633.

    Google Scholar 

  53. St. Pierre T, Clark P, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855–861.

    Article  PubMed  CAS  Google Scholar 

  54. Barton JC, McDonnell SM, Adams PC, et al. Hemochromatosis Management Working Group: Management of hemochromatosis. Ann Intern Med 1998;129:932–939.

    PubMed  CAS  Google Scholar 

  55. Harrison SA, Bacon BR. Hereditary hemochromatosis: update for 2003. J Hepatol 2003;38:S13-S23.

    Article  Google Scholar 

  56. Seamark CJ, Hutchinson M. Should asymptomatic haemochromatosis be treated? BMJ 2000;320:1314–1317.

    Article  PubMed  CAS  Google Scholar 

  57. Kaltwasser JP, Werner E, Schalk K, et al. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 1998;43:699–704.

    Article  PubMed  CAS  Google Scholar 

  58. Kowdley K, Hassanein T, Kaur S, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1995;1:237–241.

    Article  PubMed  CAS  Google Scholar 

  59. Kowdley K, Brandhagen D, Gish R, et al. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 2005;129:494–503.

    Article  PubMed  Google Scholar 

  60. Tung B, Farrell F, McCashland T, et al. Long-term follow-up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg 1999;5:369–374.

    Article  PubMed  CAS  Google Scholar 

  61. McDonnell SM, Phatak PD, Felitti V, et al.. Screening for hemochromatosis in primary care settings. Ann Intern Med 1998;129:962–970.

    PubMed  CAS  Google Scholar 

  62. Dubois S, Kowdley KV. Review article: targeted screening for hereditary haemochromatosis in high-risk groups. Aliment Pharmacol Ther 2004;20:1–14.

    Article  PubMed  CAS  Google Scholar 

  63. El-Serag H, Inadomi J, Kowdley K. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med 2000;132: 261–269.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Washington, Seattle, WA

    Cathrine J. Wheeler & Kris V. Kowdley

Authors
  1. Cathrine J. Wheeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kris V. Kowdley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kris V. Kowdley.

Additional information

The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. This article was supported in part by DK 02957 (to KVK). The authors do not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.

About this article

Cite this article

Wheeler, C.J., Kowdley, K.V. Hereditary hemochromatosis. Compr Ther 32, 10–16 (2006). https://doi.org/10.1385/COMP:32:1:10

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/COMP:32:1:10

Keywords

Search

Navigation